Skip to main content
SpringerLink
Log in

Similarities and differences between the vascular endothelial growth factor (VEGF) splice variants

  • Tumor Angiogenesis
  • Published:
Cancer and Metastasis Reviews Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Folkman J: What is the evidence that tumors are angiogenesis dependent. J Nat Cancer Inst 82: 4–7, 1990

    Google Scholar 

  2. Folkman J: Angiogenesis in cancer, vascular, rheumatoid and other disease. Nature Med 1: 27–31, 1995

    Google Scholar 

  3. Rak JW, Stcroix BD, Kerbel RS: Consequences of angiogenesis for tumor progression, metastasis, and cancer therapy. Anti-Cancer Drug 6: 3–18, 1995

    Google Scholar 

  4. Ferrara N, Henzel WJ: Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem Biophys Res Commun 161: 851–858, 1989

    Google Scholar 

  5. Leung DW, Cachianes G, Kuang WJ, Goeddel DV, Ferrara N: Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 246: 1306–1309, 1989

    Google Scholar 

  6. Tischer E, Gospodarowicz D, Mitchell R, Silva M, Schilling J, Lau K, Crisp T, Fiddes JC, Abraham JA: Vascular endothelial growth factor: a new member of the platelet-derived growth factor gene family. Biochem Biophys Res Commun 165: 1198–1206, 1989

    Google Scholar 

  7. Gospodarowicz D, Abraham JA, Schilling J: Isolation and characterization of a vascular endothelial cell mitogen produced by pituitary-derived folliculo stellate cells. Proc Natl Acad Sci USA 86: 7311–7315, 1989

    Google Scholar 

  8. Connolly DT, Olander JV, Heuvelman D, Nelson R, Monsell R, Siegel N, Haymore BL, Leimgruber R, Feder J: Human vascular permeability factor. Isolation from U937 cells. J Biol Chem 264: 20017–20024, 1989

    Google Scholar 

  9. Keck PJ, Hauser SD, Krivi G, Sanzo K, Warren T, Feder J, Connolly DT: Vascular permeability factor, an endothelial cell mitogen related to PDGF. Science 246: 1309–1312, 1989

    Google Scholar 

  10. Maglione D, Guerriero V, Viglietto G, Delli-Bovi P, Persico MG: Isolation of a human placental cDNA coding for a protein related to the vascular permeability factor. Proc Natl Acad Sci USA 88: 9267–9271, 1991

    Google Scholar 

  11. Guidi AJ, Abujawdeh G, Berse B, Jackman RW, Tognazzi K, Dvorak HF, Brown LF: Vascular permeability factor (vascular endothelial growth factor) expression and angiogenesis in cervical neoplasia. J Nat Cancer Inst 87: 1237–1245, 1995

    Google Scholar 

  12. Brown LF, Berse B, Jackman RW, Tognazzi K, Manseau EJ, Dvorak HF, Senger DR: Increased expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in kidney and bladder carcinomas. Am J Pathol 143: 1255–1262, 1993

    Google Scholar 

  13. Brown LF, Berse B, Jackman RW, Tognazzi K, Manseau EJ, Senger DR, Dvorak HF: Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in adenocarcinomas of the gastrointestinal tract. Cancer Res 53: 4727–4735, 1993

    Google Scholar 

  14. Kim KJ, Li B, Winer J, Armanini M, Gillett N, Phillips HS, Ferrara N: Inhibition of vascular endothelial growth factor induced angiogenesis suppresses tumour growth in vivo. Nature 362: 841–844, 1993

    Google Scholar 

  15. Ferrara N, Winer J, Burton T, Rowland A, Siegel M, Phillips HS, Terrell T, Keller GA, Levinson AD: Expression of vascular endothelial growth factor does not promote transformation but confers a growth advantage in vivo to Chinese hamster ovary cells. J Clin Invest 91: 160–170, 1993

    Google Scholar 

  16. Neufeld G, Tessler S, Gitay-Goren H, Cohen T, Levi BZ: Vascular endothelial growth factor and its receptors. Prog Growth Factor Res 5: 89–97: 1994

    Google Scholar 

  17. Tischer E, Mitchell R, Hartman T, Silva M, Gospodarowicz D, Fiddes JC, Abraham JA: The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing. J Biol Chem 266: 11947–11954, 1991

    Google Scholar 

  18. Houck KA, Ferrara N, Winer J, Cachianes G, Li B, Leung DW: The vascular endothelial growth factor family-identification of a fourth molecular species and characterization of alternative splicing of RNA. Mol Endocrinol 5: 1806–1814, 1991

    Google Scholar 

  19. Charnock-Jones SD, Sharkey AM, Rajput-Williams J, Burch D, Schofield JP, Fountain SA, Boocock C, Smith SK: Identification and localization of alternatively spliced mRNAs for vascular endothelial growth factor in human uterus and estrogen regulation in endometrial carcinoma cell lines. Biol Reprod 48: 1120–1128, 1993

    Google Scholar 

  20. Bacic M, Edwards NA, Merrill MJ: Differential expression of vascular endothelial growth factor (vascular permeability factor) forms in rat tissues-short communication. Growth Factors 12: 11–15, 1995

    Google Scholar 

  21. Cheung CY, Singh M, Ebaugh MJ, Brace RA: Vascular endothelial growth factor gene expression in ovine placenta and fetal membranes. Am J Obstet Gynecol 173: 753–759, 1995

    Google Scholar 

  22. Anthony FW, Wheeler T, Elcock CL, Pickett M, Thomas EJ: Identification of a specific pattern of vascular endothelial growth factor mRNA expression in human placenta and cultured placental fibroblasts. Placenta 15: 557–561, 1994

    Google Scholar 

  23. Plouet J, Schilling J, Gospodarowicz D: Isolation and characterization of a newly identified endothelial cell mitogen produced by AtT-20 cells. EMBO J 8: 3801–3806, 1989

    Google Scholar 

  24. DiSalvo J, Bayne ML, Conn G, Kwok PW, Trivedi PG, Soderman DD, Palisi TM, Sullivan KA, Thomas KA: Purification and characterization of a naturally occurring vascular endothelial growth factor placenta growth factor heterodimer. J Biol Chem 270: 7717–7723, 1995

    Google Scholar 

  25. Houck KA, Leung DW, Rowland AM, Winer J, Ferrara N: Dual regulation and vascular endothelial growth factor bioavailability by genetic and proteolytic mechanisms. J Biol Chem 267: 26031–26037, 1992

    Google Scholar 

  26. Kondo S, Matsumoto T, Yokoyama Y, Ohmori I, Suzuki H: The shortest isoform of human vascular endothelial growth factor vascular permeability factor (VEGF/VPF121) produced by Saccharomyces cerevisiae promotes both angiogenesis and vascular permeability. Bba-Gen Subjects 1243: 195–202, 1995

    Google Scholar 

  27. Gengrinovitch S, Greenberg SM, Cohen T, Gitay-Goren H, Rockwell P, Maione TE, Levi B-Z, Neufeld G: Platelet factor-4 inhibits the mitogenic activity of VEGF-121 and VEGF-165 using several concurrent mechanisms. J Biol Chem 270: 15059–15065, 1995

    Google Scholar 

  28. Park JE, Keller GA, Ferrara N: Vascular endothelial growth factor (Vegf) isoforms-differential deposition into the subepithelial extracellular matrix and bioactivity of extracellular matrix-bound VEGF. Mol Biol Cell 4: 1317–1326, 1993

    Google Scholar 

  29. Simon M, Grone HJ, Johren O, Kullmer J, Plate KH, Risau W, Fuchs E: Expressin of vascular endothelial growth factor and its receptors in human renal ontogenesis and in adult kidney. Amer J Physiol-Renal Fl Elect 37: F240-F250, 1995

    Google Scholar 

  30. Morii K, Tanaka R, Washiyama K, Kumanishi T, Kuwano R: Expression of vascular endothelial growth factor in capillary hemangioblastoma. Biochem Biophys Res Commun 194: 749–755, 1993

    Google Scholar 

  31. Harrison-Woolrych ML, Sharkey AM, Charnock-Jones DS, Smith SK: Localization and quantification of vascular endothelial growth factor messenger ribonucleic acid in human myometrium and leiomyomata. J Clin Endocrinol Metab 80: 1853–1858, 1995

    Google Scholar 

  32. Cohen T, Gitay-Goren H, Sharon R, Shibuya M, Halaban R, Levi B-Z, Neufeld G: VEGF121, a vascular endothelial growth factor (VEGF) isoform lacking heparin binding ability, requires cell surface heparan sulfates for efficient binding to the VEGF receptors of human melanoma cells. J Biol Chem 270: 11322–11326, 1995

    Google Scholar 

  33. Cohen T, Gitay-Goren H, Neufeld G, Levi B-Z: High levels of biologically active vascular endothelial growth factor (VEGF) are produced by the baculovirus expression system. Growth Factors 7: 131–138, 1992

    Google Scholar 

  34. Ferrara N, Houck K, Jakeman L, Leung DW: Molecular and biological properties of the vascular endothelial growth factor family of proteins. Endocr Rev 13: 18–32, 1992

    Google Scholar 

  35. Vaisman N, Gospodarowicz D, Neufeld G: Characterization of the receptors for vascular endothelial growth factor. J Biol Chem 265: 19461–19466, 1990

    Google Scholar 

  36. Gitay-Goren H, Soker S, Vlodavsky I, Neufeld G: The binding of vascular endothelial growth factor to its receptors is dependent on cell surface-associated heparin-like molecules. J Biol Chem 267: 6093–6098, 1992

    Google Scholar 

  37. Gitay-Goren H, Cohen T, Tessler S, Soker S, Gengrinovitch S, Rockwell P, Klagsbrun M, Levi B-Z, Neufeld G: Selective binding of VEGF121 to one of the three VEGF receptors of vascular endothelial cells. J Biol Chem 271: 5519–5523, 1996

    Google Scholar 

  38. Soker S, Fidder H, Neufeld G, Klagsbrun M: Characterization of novel VEGF binding proteins associated with tumor cells that bind VEGF165 but not VEGF121. J Biol Chem 271: 5761–5767, 1996

    Google Scholar 

  39. Devries C, Escobedo JA, Ueno H, Houck K, Ferrara N, Williams LT: The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. Science 255: 989–991, 1992

    Google Scholar 

  40. Millauer B, Shawver LK, Plate KH, Risau W, Ullrich A: Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant. Nature 367: 576–579, 1994

    Google Scholar 

  41. Seetharam L, Gotoh N, Maru Y, Neufeld G, Yamaguchi S, Shibuya M: A unique signal transduction from FLT tyrosine kinase, a receptor for vascular endothelial growth factor (VEGF). Oncogene 10: 135–147, 1995

    Google Scholar 

  42. Waltenberger J, Claessonwelsh L, Siegbahn A, Shibuya M, Heldin CH: Different signal transduction properties of KDR and Flt1, two receptors for vascular endothelial growth factor. J Biol Chem 269: 26988–26995, 1994

    Google Scholar 

  43. Tessler S, Rockwell P, Cohen T, Levi B-Z, Hicklin D, Witte L, Lemischka IR, Neufeld G: Heparin modulates the interaction of VEGF165 with soluble and cell associated flk-1 receptors. J Biol Chem 269: 12456–12461, 1994

    Google Scholar 

  44. Schraufstatter IU, Halsey WA, Hyslop PA, Cochrane CG: In vitro models for the study of oxidant-induced injury of cells in inflammation. Methods Enzymol 163: 328–339, 1988

    Google Scholar 

  45. Heck DE, Laskin DL, Gardner CR, Laskin JD: Epidermal growth factor suppresses nitric oxide and hydrogen peroxide production by keratinocytes. Potential role for nitric oxide in the regulation of wound healing. J Biol Chem 267: 21277–21280, 1992

    Google Scholar 

  46. Gospodarowicz D, Cheng J: Heparin protects basic and acidic FGF from inactivation. J Cell Physiol 128: 475–484, 1986

    Google Scholar 

  47. Volkin DB, Tsai PK, Dabora JM, Gress JO, Burke CJ, Linhardt RJ, Middaugh CR: Physical stabilization of acidic fibroblast growth factor by polyanions. Arch Biochem Biophys 300: 30–41, 1993

    Google Scholar 

  48. Vlodavsky I, Hua-Quan M, Danagher P, Ron D: Involvement of heparan-sulfate and related molecules in sequestration and growth promoting activity of fibroblast growth factor. Cancer Metastasis Rev 1996, this issue

Download references

Author information

Authors and Affiliations

  1. Department of Biology, Technion, Israel Institute of Technology, 32000, Haifa, Israel

    Gera Neufeld, Tzafra Cohen, Hela Gitay-Goren, Zoya Poltorak, Shoshana Tessler, Rivka Sharon & Stella Gengrinovitch

  2. Department of Food Engineering and Biotechnology, Technion, Israel Institute of Technology, 32000, Haifa, Israel

    Tzafra Cohen & Ben-Zion Levi

Authors
  1. Gera Neufeld
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Tzafra Cohen
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Hela Gitay-Goren
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Zoya Poltorak
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Shoshana Tessler
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Rivka Sharon
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Stella Gengrinovitch
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Ben-Zion Levi
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Neufeld, G., Cohen, T., Gitay-Goren, H. et al. Similarities and differences between the vascular endothelial growth factor (VEGF) splice variants. Cancer Metast Rev 15, 153–158 (1996). https://doi.org/10.1007/BF00437467

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00437467

Key words

Search

Navigation